Thyroid hormone within the normal range is associated with left ventricular mass in patients with hypertension

Journal of the American Society of Hypertension

Volumn 6, Issue 4, 2012, Pages 261-269

  Iida, Masato ^a   Yamamoto, Mitsuru ^a   Ishiguro, Yuuko ^a   Yamazaki, Masatoshi ^b   Honjo, Haruo ^b   Kamiya, Kaichirou ^b  

^a Mitsubishi Nagoya Hospital   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

BNP; Euthyroid; Hypertension; Left ventricular mass; Thyroid hormone

Indexed keywords

ANTIHYPERTENSIVE AGENT; BRAIN NATRIURETIC PEPTIDE; HEMOGLOBIN A1C; LIOTHYRONINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EUTHYROIDISM; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; AGED, 80 AND OVER; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; REFERENCE VALUES; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 84863719715     PISSN: 19331711     EISSN: 18787436     Source Type: Journal    
DOI: 10.1016/j.jash.2012.04.002     Document Type: Article

References (26)

1. B. Biondi, E.A. Palmieri, G. Lombardi, and S. Fazio Effects of subclinical thyroid dysfunction on the heart Ann Intern Med 137 2002 904 914 (Pubitemid 35416626)
2. I. Klein, and S. Danzi Thyroid disease and the heart Circulation 116 2007 1725 1735 (Pubitemid 47537847)
3. F. Liang, P. Webb, A. Marimuthu, S. Zhang, and D.G. Gardner Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes J Biol Chem 278 2003 15073 15083 (Pubitemid 36799841)
4. L.W. Hu, L.A. Benvenuti, E.A. Liberti, M.S. Carneiro-Ramos, and M.L. Barreto-Chaves Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling Am J Physiol Regul Integr Comp Physiol 285 2003 R1473 R1480
5. C.I. Pantos, I.S. Mourouzis, S.M. Tzeis, V. Malliopoulou, D.D. Cokkinos, and P. Asimacopoulos Propranolol diminishes cardiac hypertrophy but does not abolish acceleration of the ischemic contracture in hyperthyroid hearts J Cardiovasc Pharmacol 36 2000 384 389 (Pubitemid 30660470)
6. F. Perticone, R. Maio, C. Ruberto, S. Cassaano, G. Tripepi, and M. Perticone Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension Am J Kidney Dis 52 2008 74 84 (Pubitemid 351853261)
7. C.S. Fox, P. Gona, U. Hoffmann, S.A. Porter, C.J. Salton, and J.M. Massaro Pericardial fat, intrathoracic fat, and measures of left ventricular structure and function: the Framingham Heart Study Circulation 119 2009 1586 1591
8. R.B. Devereux, M.J. Roman, M. Paranicas, M.J. O'Grady, E.T. Lee, and T.K. Welty Impact of diabetes on cardiac structure and function: the strong heart study Circulation 101 2000 2271 2276 (Pubitemid 30317129)
9. C. Cuspidi, A. Vaccarella, F. Negri, and C. Sala Resistant hypertension and left ventricular hypertrophy:an overview J Am Soc Hypertens 4 2010 319 324
10. G. Lippi, M. Montagnana, G. Targher, G.L. Salvagno, and G.C. Guidi Relationship between thyroid status and renal function in a general population of unselected outpatients Clin Biochem 41 2008 625 627
11. N. Knudsen, P. Laurberg, L.B. Rasmussen, I. Bulow, H. Perrild, and L. Ovesen Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population J Clin Endocrinol Metab 90 2005 4019 4024 (Pubitemid 41058166)
12. M. Dorr, B. Wolff, D.M. Robinson, U. John, J. Lüdemann, and W. Meng The association of thyroid function with cardiac mass and left ventricular hypertrophy J Clin Endocrinol Metab 90 2005 673 677 (Pubitemid 40279178)
13. A. Iqbal, H. Schirmer, P. Lunde, Y. Figenschau, K. Rasmussen, and R. Jorde Thyroid stimulating hormone and left ventricular function J Clin Endocrinol Metab 92 2007 3504 3510 (Pubitemid 47435327)
14. E.N. Pearce, Q. Yang, E.J. Benjamin, J. Aragam, and R.S. Vasan Thyroid function and left ventricular structure and function in the Framingham Heart Study Thyroid 20 2010 369 373
15. A. Pingitore, G. Iervasi, A. Barison, C. Prontera, L. Pratali, and M. Emdin Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction J Card Fail 12 2006 520 526 (Pubitemid 44307709)
16. W.A. Zoghbi, M. Enriquez-Sarano, E. Foster, P.A. Grayburn, C.D. Kraft, and R.A. Levine Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802 (Pubitemid 37391035)
17. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463 (Pubitemid 41821197)
18. C. Pantos, I. Mourouzis, C. Xinaris, Z. Papadopoulou-Daifoti, and D. Cokkinos Thyroid hormone and "cardiac metamorphosis": potential therapeutic implications Pharmacol Ther 118 2008 277 294
19. G. Leoncini, F. Viazzi, D. Parodi, E. Ratto, S. Vettoretti, and V. Vaccaro Mild renal dysfunction and cardiovascular risk in hypertensive patients J Am Soc Nephrol 15 2004 S88 S90
20. M. Nakamura, F. Tanaka, K. Sato, T. Segawa, and M. Nagano B-type natriuretic peptide testing for structural heart disease screening: a general population-based study J Card Fail 11 2005 705 712 (Pubitemid 41797501)
21. B.O. Asvold, T. Bjoro, T.I. Nilsen, and L.J. Vatten Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study J Clin Endocrinol Metab 92 2007 841 845 (Pubitemid 46465652)
22. A. Iqbal, Y. Figenschau, and R. Jorde Blood pressure in relation to serum thyrotropin: the Tromso Study J Hum Hypertens 20 2006 932 936 (Pubitemid 44782826)
23. D. Liu, F. Jiang, Z. Shan, B. Wang, J. Wang, and Y. Lai A cross-sectional survey of relationship between serum TSH level and blood pressure J Hum Hypertens 24 2010 134 138
24. C. Pantos, I. Paizis, I. Mourouzis, P. Moraitis, S. Tzeis, and E. Karamanoli Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning Horm Metab Res 37 2005 500 504 (Pubitemid 41306400)
25. J.S. Healey, and S.J. Connolly Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target Am J Cardiol 91 2003 9G 14G (Pubitemid 36638516)
26. J. Heeringa, E.H. Hoogendoorn, W.M. van der Deure, A. Hofman, R.P. Peeters, and W.C. Hop High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study Arch Intern Med 168 2008 2219 2224